Migraine Drug Atogepant Works for Difficult Cases, Study Finds
A recently approved preventative migraine drug called atogepant (branded Qulipta) seems to help even the most difficult cases, preliminary research out this week has found. The study showed that patients who hadn’t responded to other treatments experienced noticeably fewer days without migraine while on atogepant than those given a placebo. The Food and Drug Administration expanded the drug’s intended use this month, approving it for adults with chronic migraines.Won’t Virtual Reality Make Me Sick?Atogepant was developed…